Hepatic Ceramide May Mediate Brain Insulin Resistance and Neurodegeneration in Type 2 Diabetes and Non-Alcoholic Steatohepatitis

Journal of Alzheimer's Disease - Netherlands
doi 10.3233/jad-2009-0984